Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Dipanjan BanchurSince

Berkshire Hathaway (BRK.B) Earnings Alert: Key Insights for Investors

Berkshire Hathaway (BRK.B) will release its fourth-quarter results on February 22. The company is expected to report a year-over-year rise in earnings and revenue. I’ve discussed several key insights that investors must consider before its earnings release. Keep reading….

StockNews.com

Should You Buy, Hold, or Sell Realty Income (O) and Public Storage (PSA) Ahead of Earnings?

REITs Public Storage (PSA) and Realty Income Corporation (O) are scheduled to release their fourth-quarter financials on February 21. We assess the two REIT’s fundamentals to determine how investors should position themselves before their numbers are reported. Read on….

StockNews.com

Home Depot (HD) Earnings Impact: Buy or Watch Moves?

World’s largest home improvement retailer, The Home Depot (HD), will release its fourth-quarter results on February 20. The company is expected to report a year-over-year decline in earnings and revenue. Therefore, should investors consider buying the stock ahead of its earnings? Read on to learn my view….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Dominate the Market With 3 Biotech Stocks

The biotech industry’s growth prospects look promising due to considerable investments in research and development (R&D), an innovative drugs pipeline, government initiatives, the growing popularity of personalized medicine, drug approvals, expanding healthcare needs, etc. Amid this backdrop, investors could consider buying fundamentally strong biotech stocks Innoviva (INVA), Foghorn Therapeutics (FHTX),…

StockNews.com

This Week's Key Luxury Stock Gainers

The luxury goods industry appears well-positioned to benefit from changing consumer trends, rising disposable incomes, integration of advanced technologies, growing popularity of e-commerce platforms, ease of payments, etc. Amid this backdrop, investors could consider buying fundamentally strong luxury stocks The Buckle (BKE), Abercrombie & Fitch (ANF), and Vera Bradley (VRA).…

StockNews.com

STLA Earnings Impact: Buy or Hold Decision?

Hoofddorp, the Netherlands-based Stellantis (STLA), will release its full-year results on February 15. The company is expected to report a year-over-year rise in earnings and revenue. Therefore, should investors consider buying the stock pre-earnings? Read on to learn my view….

StockNews.com

Southern Co. (So): Buy or Watch Ahead of Earnings?

Utility major The Southern Company (SO) will release its fourth-quarter results on February 15. The company is expected to report a year-over-year growth in earnings and revenue. Therefore, should investors consider buying the stock ahead of its earnings? Read on to learn my view….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Applied Materials (AMAT): Earnings Expectations and Strategies

Santa Clara, California-based Applied Materials will report its first-quarter results on February 15. The company is expected to report a year-over-year decline in earnings and revenue. How should investors position themselves before its earnings release? Read on to learn my view….

StockNews.com

Cisco Systems (CSCO): Buy or Hold Pre-Earnings?

San Jose, California-based network giant Cisco (CSCO) will release its second-quarter results on February 14. The company is expected to report a year-over-year decline in earnings and revenue. Therefore, should investors consider buying the stock pre-earnings? Read on to learn my view….

StockNews.com

Marriott International (MAR) Earnings Alert: Buy or Sell Signals?

Marriott International (MAR) will release its fourth-quarter results on February 13. The company is expected to report year-over-year growth in earnings and revenue. Therefore, should investors consider buying the stock now? Read on to learn my view….

StockNews.com

Moody's (MCO): Earnings Analysis for Investors

Global integrated risk assessment company Moody’s (MCO) will report its fourth-quarter results on February 13. The company is expected to report year-over-year growth in earnings and revenue. We assess whether it is worth buying the stock now. Keep reading.

StockNews.com

After Q4 Earnings Beat, Should Investors Add Chipotle (CMG) to Their Portfolios?

StockNews.com

Buy or Sell These 3 Bank Stocks?

Prolonged exposure to high-interest rates, risk of defaults on commercial real estate loans, elevated deposit costs, diminished credit demand, and stringent lending standards are expected to pile more pressure on U.S. banks. Considering these factors, should investors consider investing in foreign bank stocks Banco Santander (SAN), Akbank (AKBTY), and First…

StockNews.com

McDonald's (MCD) Financial Health Check: Buy, Hold, or Sell?

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Motorola Solutions (MSI) Quarterly Earnings: What to Watch For

Chicago-based Motorola Solutions (MSI) will release its fourth-quarter and full-year results on February 8. Given the strong demand for its products and solutions, the company has bolstered its revenue and earnings estimates for fiscal 2023. Therefore, should investors consider buying the stock now? Read on to learn my view….

StockNews.com

SPGI Quarterly Earnings Preview: Buy or Hold Decision?

S&P Global (SPGI) will release its fourth-quarter results on February 8. Analysts expect the company to report a year-over-year increase in revenue and earnings for the quarter. Moreover, the company is expected to finish fiscal 2023 on a solid note. Therefore, should investors consider buying the stock now? Read on…

StockNews.com

CVS Health (CVS) Pre-Earnings Analysis: Buy or Hold?

The largest U.S. drugstore chain, CVS Health (CVS), will release its fourth-quarter results on February 7. The company is expected to report year-over-year growth in revenue and earnings. With the expected rise in medical costs during the fourth quarter, should investors consider buying the stock now? Read on to learn…

StockNews.com

Gilead (GILD) Quarterly Earnings: Buy or Sell Signal?

Biotech major Gilead Sciences (GILD) will release its fourth-quarter results on February 6. The company is expected to report growth in earnings over the prior-year quarter, but its revenue is expected to decline. Given the expected decline in its revenue, how should investors play this stock? Read on to learn…

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Lucrative Pharma Stocks for Portfolio Success

The pharmaceutical industry holds immense promise due to the rapidly aging population, growing healthcare needs, breakthroughs in new drugs and therapies, and the rise in chronic diseases. Therefore, it could be wise to add fundamentally strong pharma stocks Supernus Pharmaceuticals (SUPN), Eton Pharmaceuticals (ETON), and Viatris (VTRS) to one’s portfolio.…

StockNews.com

3 Tech Wonders Unlocking Gains

Rising digitization spending and the adoption of cutting-edge technologies are driving the tech industry forward. Amid this backdrop, it could be wise to consider buying fundamentally strong tech stocks Garmin (GRMN), NetScout (NTCT), and Stratasys (SSYS). Read more….

StockNews.com

Pharma Stock Analysis: Buy, Hold, or Sell These 4?

Amid rising global medical needs, an aging population, and technological advancements, the pharmaceutical industry is expected to witness robust growth over the coming years. Given this positive backdrop, let’s analyze the investment prospects of pharma stocks Madrigal (MDGL), Pfizer (PFE), Astellas (ALPMY), and Novo Nordisk (NVO). Read on.

StockNews.com

3 Software Application Stocks Making Moves on Wall Street

The software industry’s growth prospects look promising thanks to continued digitalization initiatives, growing adoption of the public cloud, rise in cyber threats, and the integration of emerging technologies. Therefore, it could be wise to buy fundamentally strong software stocks with steady returns, Dassault Systems (DASTY), Instructure (INST), and MarketWise (MKTW).…

StockNews.com

AMD Earnings Watch: Analyzing Potential Buy Moves

Advanced Micro Devices (AMD) will release its fourth-quarter earnings on January 30. With analysts expecting the company to report a year-over-year increase in EPS and revenue, we assess whether it could be wise to buy the stock ahead of the earnings release. Keep reading….

StockNews.com

Top 3 China Stock Picks for Monthly Success

After encountering several challenges over the past few years, Chinese stocks are expected to perform well, given the slew of corrective measures being taken up by the nation. Given this backdrop, investors could consider investing in fundamentally strong Chinese stocks Youdao (DAO), Ping An Insurance (Group) Company of China (PNGAY),…

StockNews.com

Buy, Hold, or Sell? Analyzing 3 Biotech Stocks Investors Are Watching

Amid the use of advanced technologies, personalized medicines, demand for quality treatments and therapies, and an aging population, the biotech industry appears to be on a steady path for expansion. Given this backdrop, let’s analyze the fundamentals of Biogen (BIIB), BioNTech (BNTX), and Kura (KURA) to determine which of these…

1 2 3 4 5

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.